Type of institution: University/Higher Education Institution
Level: Undergraduate
CRICOS: 01032F

The Bachelor of Physiotherapy is a 4-year full-time program that prepares graduates to become effective, culturally-appropriate practitioners with a focus on the Physiotherapist-client relationship. This program includes a suite of foundational courses which align with specialised Physiotherapy-specific courses and clinical placement experiences. There is a strong focus on ethical and professional communication and behaviours as well as on development of high-level communication skills with clients and as part of collaborative multi-disciplinary practice. The program also has a strong focus on evidence-based and reflective practice ensuring graduates will be well prepared to meet the challenge of current and future health provision across the many clinical and non-clinical areas in which Physiotherapists are employed. Graduates from this program will be eligible for registration as a Physiotherapist with the Australian Health Practitioner Registration Agency (AHPRA).

Structure

Credit Point 800

Subjects

  • Physiotherapy

Standard entry requirements

  • Applicant with recent Secondary Education - Indicative minimum selection rank of 90 or equivalent with a pass in ATAR English, ATAR Literature or ATAR English as an Additional Languge or Dialect (EALD). Minimum International Baccalaureate (IB) of 33
  • Refer to Notre Dame general admission criterial: https://www.notredame.edu.au/study/admission-requirements

Recognition

Physiotherapy Board of Australia; Australian Physiotherapy Association

Study information

CampusFeesMid year intakeAttendance
Fremantle International: $152,768 No
  • Full-time : 4 years

Fee comments

Campuses: Fremantle.

Australian Citizens may be eligible to defer costs on a HECS-HELP loan scheme.

Related courses

Browse more courses
Is the information on this page correct? Request update
Enquire about this course

Are you currently in Australia?

You must agree before submitting.

Subscribe to our newsletter

Join the conversation